| Alternative Names: | nicotinamide phosphoribosyltransferase |
| Background: | Nicotinamide phosphoribosyltransferase (NAMPT), also known as pre-B-cell colony-enhancing factor, is the rate-limiting enzyme that converts nicotinamide to nicotinamide mononucleotide (NMN) from nicotinamide in the salvage pathway of NAD biosynthesis in mammals. Nicotinamide mononucleotide adenylyltransferase 1 converts NMN to NAD. The expression of NAMPT is upregulated during activation of immune cells such as monocytes, macrophages, dendritic cells, T and B cells, as well as in amniotic epithelial cells upon stimulation with several inflammatory cytokines. NAMPT-specific inhibitor, FK866 was found to deplete intracellular NAD content, resulting in apoptotic cell death in many cancer cell lines without any DNA damaging effect. |
| Gene ID Human: | 10135 |
| Gene ID Mouse: | 59027 |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
| Product Type: | Protein |
| Shipping: | dry ice |
| Size: | 100 ug |
| Species Reactivities: | Human |
| Status: | RUO |
| Storage: | -70℃ |
| Target: | NAMPT |
Applications:
There are no references for NAMPT(Human, Active) at this time.
